All posts
-
New US dietary guidelines elevate meat and full-fat dairy, ignite protein debate: ‘Most Americans already eat plenty’
Nutritional experts have actually invited the focus on lowering usage of extremely refined foods in the brand-new Dietary Guidelines for Americans, yet state their concentrate on p…
-
Exclusive: Biographica raises $9.5m for AI-driven crop design, unveils partnership with BASF
Biographica, a startup deploying AI and machine learning to accelerate and improve the crop trait development process by identifying high value targets for gene-editing, has raised…
-
Reduced import of pharmaceuticals leads to smallest trade deficit in the US since 2009
According to Bloomberg, the decrease in the profession deficiency is specifically because of a decrease in the import of drugs.
-
US company unveils candidate for Gubra partnership
As an outcome of the choice, Gubra is readied to get a landmark repayment of $4 million, equal to roughly DKK 26 million.
-
Amgen acquires British Dark Blue Therapeutics for USD 840m
Amgen enhances cancer cells study with procurement of Dark Blue Rehabs.
-
Lift Biosciences appoints new CEO: Will open “a new front” against immunotherapy
The British biotech business is presently preparing a Stage 1 test, which will certainly start in very early 2027 to evaluate the lead prospect as a therapy for cervical cancer cel…
-
Weight loss drugs lose effectiveness after two years
Research reveals long-lasting techniques are required to stay clear of weight gain after drug ends.
-
Chinese drug manufacturers signed record-breaking licensing deals in 2025
Loads of billion-dollar bargains in between Chinese companies and worldwide pharma titans drove the document high.
-
GSK hepatitis B drug shows promising trial results
GSK’s therapy can enhance yearly incomes by numerous billion extra pounds.
-
Eli Lilly completes billion-dollar acquisition of US biotech company
Eli Lilly announced the agreement Wednesday following the close of trading in the US.
